Latest Research & News
By Gavin Magor On November 15, 202610:00 AM Eastern
Join Gavin Magor LIVE November 19 for a look inside The Weiss Ultimate Portfolio.
By Sean Brodrick On November 15, 202608:00 AM Eastern
Buried in Anthropic’s IPO roadshow presentation could be a bigger problem for Nvidia than the scandal.
By Beth Canova On November 14, 202612:00 PM Eastern
Trump Jr. and Kalshi just parted ways. But the bigger story is the Nov. 18 CFTC deadline, and a way to use prediction market odds without placing a bet.
By Sean Brodrick On November 14, 202610:00 AM Eastern
Key Takeaways With high-grade silver veins, Pacifica Silver should be on your radar. Sean Brodrick sits down with CEO Todd Anthony. This junior miner has big-pocketed backers. ...
By Jim Nelson On November 14, 202608:00 AM Eastern
That didn’t stop us from filling your inbox — once you can open it — with expert advice.
By Dawn Pennington On November 13, 202605:32 PM Eastern
Plus a 220% combined win and six new ideas.
By Mandeep Rai On November 13, 202604:25 PM Eastern
Each has strong finances, little debt and a big lead on the S&P 500 this past month. Here’s the full list.
By Juan M. Villaverde On November 13, 202604:00 PM Eastern
What I thought was an 80-day correction may actually be a longer cycle downturn. Here’s how that changes my outlook through 2026 … and what stays the same.
By Al Qureiyeh On November 13, 202603:25 PM Eastern
AbbVie earns about three-quarters of its sales at home, so a strong dollar barely dents it. Our target points to about 6% upside, plus a 2.5% dividend.
Weiss Ultimate Portfolio
Subscription
By Gavin Magor On November 13, 202603:00 PM Eastern
Plus, a personal invitation to my fireside chat on Thursday, Nov. 19, at 2 p.m. Eastern.